Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:1487-1490
Published online before print March 13, 2008, doi: 10.1161/STROKEAHA.107.502658
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/5/1487    most recent
STROKEAHA.107.502658v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stam, J.
Right arrow Articles by Reekers, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stam, J.
Right arrow Articles by Reekers, J. A.
Related Collections
Right arrow Heparin
Right arrow Cerebral Venous Thrombosis
Right arrow Thrombolysis
Right arrow Other Stroke

(Stroke. 2008;39:1487.)
© 2008 American Heart Association, Inc.


Original Contributions

Endovascular Thrombectomy and Thrombolysis for Severe Cerebral Sinus Thrombosis

A Prospective Study

Jan Stam, MD, PhD; Charles B.L.M. Majoie, MD, PhD; Otto M. van Delden, MD, PhD; Krijn P. van Lienden, MD, PhD Jim A. Reekers, MD, PhD

From the Departments of Neurology (J.S.) and Radiology (C.B.L.M.M., O.M.v.D., K.P.v.L., J.A.R.), Academic Medical Centre, University of Amsterdam, The Netherlands.

Correspondence to Prof Dr J. Stam, Department of Neurology (H2-226), Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. E-mail J.Stam{at}amc.uva.nl

Background and Purpose— Most patients with cerebral sinus thrombosis (CST) recover after treatment with heparin, but a subgroup has a poor prognosis. Those patients may benefit from endovascular thrombolysis.

Methods— Prospective case series. Patients with sinus thrombosis were selected for thrombolysis if they had an altered mental status, coma, straight sinus thrombosis, or large space-occupying lesions. Urokinase was infused into the sinuses (bolus 120 to 600x103 U; then 100x103 U/h) via a jugular catheter, in 15 cases combined with mechanical thrombus disruption or removal.

Results— We treated 20 patients (16 women), mean age 32 years. Twelve patients were comatose and 14 had hemorrhagic infarcts before thrombolysis. Twelve patients recovered (Rankin score 0 to 2), 2 survived with handicaps, and 6 died. Factors associated with a fatal outcome were leukemia (3/6 versus 0/14, P=0.02) and large hemorrhagic infarcts (4/6 versus 2/14, P=0.04). Seizures were less frequent in the fatal cases (P=0.05). Patients who died had a larger mean lesion surface than survivors (30.5 versus 13.6 cm2; P=0.03), larger midline shift (5.2 versus 1.7 mm; P=0.02), and a more rapid course (2.7 versus 8.2 days; P=0.01). Five patients who died had large hemispheric infarcts and edema before thrombolysis, causing herniation. Five patients had increased cerebral hemorrhage (3 minor, 2 major) after thrombolysis.

Conclusions— Thrombolysis can be effective for severe sinus thrombosis, but patients may deteriorate because of increased cerebral hemorrhage. Patients with large infarcts and impending herniation did not benefit.


Key Words: sinus thrombosis • intracranial • thrombolytic therapy




This article has been cited by other articles:


Home page
StrokeHome page
J. M. Coutinho, C. B.L.M. Majoie, B. A. Coert, and J. Stam
Decompressive Hemicraniectomy in Cerebral Sinus Thrombosis: Consecutive Case Series and Review of the Literature
Stroke, June 1, 2009; 40(6): 2233 - 2235.
[Abstract] [Full Text] [PDF]